Chronic Disease Management Market Trends

Growth Drivers 

• Benefits of tech-based solutions in medical care: The rapid penetration of AI and cloud in healthcare is fostering a pre-established trading atmosphere for the chronic disease management market. Remote patient monitoring, AI-powered diagnosis, and mobile health apps are evolving the approach to managing associated ailments and improving outcomes, creating a surge in this sector. For instance, in June 2024, Verily shared its vision of commercializing its AI-driven personalized chronic care solution, Lightpath, in early 2026. It is intended to support interchange between allocated modular programs, such as Metabolic Intensive, Weight Loss Intensive, Metabolic Improvement, and Metabolic Achievement, as per user's needs.
• Growing acceptance toward data-driven solutions: As consumers seek more value-based healthcare, the chronic disease management market witnesses a strong push toward wide adoption. Particularly, after the pandemic struck, the importance and economic significance of data-driven remote care have magnified. This also created an adaptive consumer base for this sector by streamlining virtual assistance and telemedicine as essential clinical assets.  

Challenges 

• High initial and additional cost of implementation: Chronic diseases, such as cancer, are long-term illnesses that need treatment for lifetime treatment in most cases. Thus, the existing financial burden of primary medications and surgical procedures may create a barrier between service providers and consumers in the chronic disease management market. In addition, a lack of resources in underserved regions limits worldwide expansion in this sector due to the issues in availability and accessibility.
• Lack of workforce with cross-functional skills: In both remote and on-premises healthcare settings across the globe, the shortage of trained caregivers is becoming a prominent issue. According to an OECD report, the required supply of care workers for older people in the world is poised to demand 13.5 million new recruits by 2040. This signifies the possible future deficiency in an efficient workforce, which is necessary to implement solutions from the chronic disease management market.